Journals
Publish with us
Publishing partnerships
About us
Blog
Pain Research and Management
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Pain Research and Management
/
2019
/
Article
/
Tab 6
/
Clinical Study
Gabapentin versus Transdermal Fentanyl Matrix for the Alleviation of Chronic Neuropathic Pain of Radicular Origin: A Randomized Blind Multicentered Parallel-Group Noninferiority Trial
Table 6
Incidence of AEs in ≥5% of patients by treatment.
AE,
n
(%)
Fentanyl matrix (
N
= 52)
Gabapentin (
N
= 56)
Total (
N
= 108)
Dizziness
16 (30.8%)
25 (44.6%)
41 (38.0%)
Somnolence
15 (28.8%)
21 (37.5%)
36 (33.3%)
Nausea
19 (36.5%)
4 (7.1%)
23 (21.3%)
Constipation
8 (15.4%)
10 (17.9%)
18 (16.7%)
Vomiting
11 (21.2%)
2 (3.6%)
13 (12.0%)
Asthenia
7 (13.5%)
8 (14.3%)
15 (13.9%)
Headache
3 (5.8%)
4 (7.1%)
7 (6.5%)
AE: adverse event.